Anti-inflammatory effects of apocynin: a narrative review of the evidence

References

• Altintas R, Polat A, Vardi N, Oguz F, Beytur A, Sagir M, Yildiz A, Parlakpinar H. 2013. The protective effects of apocynin on kidney damage caused by renal ischemia/reperfusion. J Endourol. 27:617–624.
   PubMed Web of Science ®Google Scholar
• Araujo M, Wilcox CS. 2014. Oxidative stress in hypertension: role of the kidney. Antioxid Redox Signal. 20:74–101.
   PubMed Web of Science ®Google Scholar
• Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, Colli S. 2004. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic Biol Med. 37:156–165.
   PubMed Web of Science ®Google Scholar
• Bedard K, Krause KH. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 87:245–313.
   PubMed Web of Science ®Google Scholar
• Beswick RA, Dorrance AM, Leite R, Webb RC. 2001. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 38:1107–1111.
   PubMed Web of Science ®Google Scholar
• Brown GC. 2007. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans. 35:1119–1121.
   PubMed Web of Science ®Google Scholar
• Brown GC, Neher JJ. 2010. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol. 41:242–247.
   PubMed Web of Science ®Google Scholar
• Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. 2021. Features, evaluation and treatment Coronavirus (COVID-19). StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK554776/.
   Google Scholar
• Chan EC, Datla SR, Dilley R, Hickey H, Drummond GR, Dusting GJ. 2007. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits. Cardiovasc Res. 75:710–718.
   PubMed Web of Science ®Google Scholar
• Chian CF, Chiang CH, Yuan-Jung C, Chuang CH, Liu SL, Yi-Han J, Zhang H, Ryu JH. 2012. Apocynin attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model. Shock. 38:196–202.
   PubMed Web of Science ®Google Scholar
• Conti P, Caraffa A, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G, Toniato E. 2020a. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). J Biol Regul Homeost Agents. 34:1623–1627.
   PubMed Web of Science ®Google Scholar
• Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. 2020b. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 34:327–331.
   PubMed Web of Science ®Google Scholar
• Cross AL, Hawkes J, Wright HL, Moots RJ, Edwards SW. 2020. APPA (apocynin and paeonol) modulates pathological aspects of human neutrophil function, without supressing antimicrobial ability, and inhibits TNFalpha expression and signalling. Inflammopharmacology. 28:1223–1235.
   Web of Science ®Google Scholar
• Dodd-O JM, Welsh LE, Salazar JD, Walinsky PL, Peck EA, Shake JG, Caparrelli DJ, Ziegelstein RC, Zweier JL, Baumgartner WA, Pearse DB. 2004. Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury. Am J Physiol Heart Circ Physiol. 287:H927–H936.
   Web of Science ®Google Scholar
• Engels F, Renirie BF, Hart BA, Labadie RP, Nijkamp FP. 1992. Effects of apocynin, a drug isolated from the roots of picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett. 305:254–256.
   PubMed Web of Science ®Google Scholar
• Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. 2002. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem. 81:1285–1297.
   PubMed Web of Science ®Google Scholar
• Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA. 2004. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 13:563–567.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Wang HD, Mcneill JR. 2004. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br J Pharmacol. 141:562–573.
   PubMed Web of Science ®Google Scholar
• Gjertsen FB, Solheim E, Scheline RR. 1988. Metabolism of aromatic plant ketones in rats: acetovanillone and paeonol. Xenobiotica. 18:225–234.
   PubMed Web of Science ®Google Scholar
• Gregersen BI, Halvorsen B. 2017. Inflammatory mechanisms in atherosclerosis. Atherosclerosis - Yesterday, Today and Tomorrow. 7:328–331.
   Google Scholar
• Groemping Y, Rittinger K. 2005. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J. 386:401–416.
   PubMed Web of Science ®Google Scholar
• Guan Q, Zhang J. 2017. Recent advances: The imbalance of cytokines in the pathogenesis of inflammatory bowel disease. Mediators Inflamm. 2017:4810258.
   PubMed Web of Science ®Google Scholar
• Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM. 1993. Induction of nitric oxide synthase in asthma. Lancet. 342:1510–1513.
   PubMed Web of Science ®Google Scholar
• Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF. 2002. NAD(p)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension. 40:755–762.
   PubMed Web of Science ®Google Scholar
• Harirforoosh S, Jamali F. 2009. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 8:669–681.
   PubMed Web of Science ®Google Scholar
• Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schöneich C, Engelhardt JF. 2008. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest. 118:659–670.
   PubMed Web of Science ®Google Scholar
• Hart BA, Copray S, Philippens I. 2014. Apocynin, a low molecular oral treatment for neurodegenerative disease. Biomed Res Int. 2014:298020.
   PubMed Web of Science ®Google Scholar
• Hart T, B A, Simons JM, Shoshan K-S, Bakker NPM, Labadie RP. 1990. Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radical Biol Med. 9:127–131.
   Web of Science ®Google Scholar
• Hawrylowicz CM, Howells GL, Feldmann M. 1991. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 174:785–790.
   PubMed Web of Science ®Google Scholar
• Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 391:591–594.
   PubMed Web of Science ®Google Scholar
• Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schröder K, Brandes RP. 2008. Apocynin Is Not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension. 51:211–217.
   PubMed Web of Science ®Google Scholar
• Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. 1993. Inhibition of low-density lipoprotein oxidation by nitric oxide. potential role in atherogenesis. FEBS Lett. 334:170–174.
   PubMed Web of Science ®Google Scholar
• Holland JA. 1999. Prevention of atherosclerosis using NADPH oxidase inhibitors. US patent no. 5902831.
   Google Scholar
• Holland JA, Meyer JW, Chang MM, O'donnell RW, Johnson DK, Ziegler LM. 1998. Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium. 6:113–121.
   PubMed Web of Science ®Google Scholar
• Holland JA, Meyer JW, Schmitt ME, Sauro MD, Johnson DK, Abdul-Karim RW, Patel V, Ziegler LM, Schillinger KJ, Small RF, Lemanski LF. 1997. Low-density lipoprotein stimulated peroxide production and endocytosis in cultured human endothelial cells: mechanisms of action. Endothelium. 5:191–207.
   PubMed Web of Science ®Google Scholar
• Hougee S, Hartog A, Sanders A, Graus YM, Hoijer MA, Garssen J, Van Den Berg WB, Van Beuningen HM, Smit HF. 2006. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur J Pharmacol. 531:264–269.
   PubMed Web of Science ®Google Scholar
• Hu L, Zhang Y, Lim PS, Miao Y, Tan C, Mckenzie KU, Schyvens CG, Whitworth JA. 2006. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am J Hypertens. 19:413–418.
   PubMed Web of Science ®Google Scholar
• Hundelshausen PV, Weber KSC, Huo Y, Proudfoot AEI, Nelson PJ, Ley K, Weber C. 2001. RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium. Circulation. 103:1772–1777.
   Web of Science ®Google Scholar
• Hunter P. 2012. The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Rep. 13:968–970.
   Web of Science ®Google Scholar
• Hwang YJ, Nam SJ, Chun W, Kim SI, Park SC, Kang CD, Lee SJ. 2019. Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model. PLoS One. 14:e0217642.
   Web of Science ®Google Scholar
• Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Bramanti P, Cuzzocrea S. 2011. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol. 81:636–648.
   PubMed Web of Science ®Google Scholar
• Ismail HM, Scapozza L, Ruegg UT, Dorchies OM. 2014. Diapocynin, a dimer of the NADPH oxidase inhibitor apocynin, reduces ROS production and prevents force loss in eccentrically contracting dystrophic muscle. PLOS ONE. 9:e110708.
   PubMed Web of Science ®Google Scholar
• Jackman KA, Miller AA, De Silva TM, Crack PJ, Drummond GR, Sobey CG. 2009. Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol. 156:680–688.
   PubMed Web of Science ®Google Scholar
• Jantaree P, Lirdprapamongkol K, Kaewsri W, Thongsornkleeb C, Choowongkomon K, Atjanasuppat K, Ruchirawat S, Svasti J. 2017. Homodimers of vanillin and apocynin decrease the metastatic potential of human cancer cells by inhibiting the FAK/PI3 K/Akt signaling pathway. J Agric Food Chem. 65:2299–2306.
   PubMed Web of Science ®Google Scholar
• Jensen MD, Sheng W, Simonyi A, Johnson GS, Sun AY, Sun GY. 2009. Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes. Neurochem Int. 55:362–368.
   Web of Science ®Google Scholar
• Johnson DK, Schillinger KJ, Kwait DM, Hughes CV, Mcnamara EJ, Ishmael F, O'donnell RW, Chang MM, Hogg MG, Dordick JS, et al. 2002. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium. 9:191–203.
   PubMed Web of Science ®Google Scholar
• Kahles T, Kohnen A, Heumueller S, Rappert A, Bechmann I, Liebner S, Wittko IM, Neumann-Haefelin T, Steinmetz H, Schroeder K, Brandes RP. 2010. NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice. Neurobiol Dis. 40:185–192.
   PubMed Web of Science ®Google Scholar
• Kellner M, Noonepalle S, Lu Q, Srivastava A, Zemskov E, Black SM. 2017. ROS signaling in the pathogenesis of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Adv Exp Med Biol. 967:105–137.
   PubMed Web of Science ®Google Scholar
• Kelly KA, Li X, Tan Z, Vangilder RL, Rosen CL, Huber JD. 2009. NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Res. 1292:165–172.
   Web of Science ®Google Scholar
• Khanicheh E, Qi Y, Xie A, Mitterhuber M, Xu L, Mochizuki M, Daali Y, Jaquet V, Krause KH, Ruggeri ZM, et al. 2013. Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties. Arterioscler Thromb Vasc Biol. 33:2187–2192.
   PubMed Web of Science ®Google Scholar
• Khor TO, Huang MT, Prawan A, Liu Y, Hao X, Yu S, Cheung WK, Chan JY, Reddy BS, Yang CS, Kong AN. 2008. Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res (Phila). 1:187–191.
   PubMed Web of Science ®Google Scholar
• Kim SY, Moon KA, Jo HY, Jeong S, Seon SH, Jung E, Cho YS, Chun E, Lee KY. 2012. Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation. Immunol Cell Biol. 90:441–448.
   PubMed Web of Science ®Google Scholar
• Kinkade K, Streeter J, Miller FJ. 2013. Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. Int J Mol Sci. 14:17017–17028.
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Matsumura T, Ishii N, Fukuda K, Senokuchi T, Motoshima H, Kondo T, Taketa K, Kawasaki S, Hanatani S, et al. 2013. Apocynin suppresses the progression of atherosclerosis in apoE-deficient mice by inactivation of macrophages. Biochem Biophys Res Commun. 431:124–130.
   Web of Science ®Google Scholar
• Klees RF, De Marco PC, Salasznyk RM, Ahuja D, Hogg M, Antoniotti S, Kamath L, Dordick JS, Plopper GE. 2006. Apocynin derivatives interrupt intracellular signaling resulting in decreased migration in breast cancer cells. J Biomed Biotechnol. 2006:87246.
   PubMed Web of Science ®Google Scholar
• Komiya M, Fujii G, Miyamoto S, Takahashi M, Ishigamori R, Onuma W, Ishino K, Totsuka Y, Fujimoto K, Mutoh M. 2015. Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK-A(y) and Apc mutant Min mice. Cancer Sci. 106:1499–1505.
   Web of Science ®Google Scholar
• Kouhpayeh S, Shariati L, Boshtam M, Al E. 2020. The molecular story of COVID-19; NAD+ depletion addresses all questions in this infection Med & Pharmacol, preprint.
   Google Scholar
• Kruse ML, Friedrich M, Arlt A, Rocken C, Egberts JH, Sebens S, Schafer H. 2016. Colonic lamina propria inflammatory cells from patients with IBD induce the nuclear factor-E2 related factor-2 thereby leading to greater proteasome activity and apoptosis protection in human colonocytes. Inflamm Bowel Dis. 22:2593–2606.
   PubMed Web of Science ®Google Scholar
• Laine L, Smith R, Min K, Chen C, Dubois RW. 2006. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 24:751–767.
   PubMed Web of Science ®Google Scholar
• Lam G, Apostolopoulos V, Zulli A, Nurgali K. 2015. NADPH oxidases and inflammatory bowel disease. Curr Med Chem. 22:2100–2109.
   Web of Science ®Google Scholar
• Lee SH, Kwon JE, Cho ML. 2018. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 16:26–42.
   PubMed Web of Science ®Google Scholar
• Li B, Guo YS, Sun MM, Dong H, Wu SY, Wu DX, Li CY. 2008. The NADPH oxidase is involved in lipopolysaccharide-mediated motor neuron injury. Brain Res. 1226:199–208.
   Web of Science ®Google Scholar
• Li Z, Wang Y. 2015. Effect of NADPH oxidase inhibitor-apocynin on the expression of Src homology-2 domain-containing phosphatase-1 (SHP-1) exposed renal ischemia/reperfusion injury in rats. Toxicol Rep. 2:1111–1116.
   Web of Science ®Google Scholar
• Luchtefeld R, Luo R, Stine K, Alt ML, Chernovitz PA, Smith RE. 2008. Dose formulation and analysis of diapocynin. J Agric Food Chem. 56:301–306.
   PubMed Web of Science ®Google Scholar
• Marin M, Giner RM, Rios JL, Recio Mdel C. 2013. Protective effect of apocynin in a mouse model of chemically-induced colitis. Planta Med. 79:1392–1400.
   PubMed Web of Science ®Google Scholar
• Mendelsohn AR, Larrick JW. 2017. The NAD+/PARP1/SIRT1 axis in aging. Rejuvenation Res. 20:244–247.
   PubMed Web of Science ®Google Scholar
• Meng R, Zhu DL, Bi Y, Yang DH, Wang YP. 2010. Apocynin improves insulin resistance through suppressing inflammation in high-fat diet-induced obese mice. Mediators Inflamm. 2010:858735.
   PubMed Web of Science ®Google Scholar
• Mileo AM, Miccadei S. 2016. Polyphenols as modulator of oxidative stress in cancer disease: New therapeutic strategies. Oxid Med Cell Longev. 2016:6475624.
   PubMed Web of Science ®Google Scholar
• Moura FA, De Andrade KQ, Dos Santos JCF, Araujo ORP, Goulart MOF. 2015. Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox Biol. 6:617–639.
   PubMed Web of Science ®Google Scholar
• Mouzaoui S, Djerdjouri B, Makhezer N, Kroviarski Y, El-Benna J, Dang PM. 2014. Tumor necrosis factor-alpha-induced colitis increases NADPH oxidase 1 expression, oxidative stress, and neutrophil recruitment in the colon: preventive effect of apocynin. Mediators Inflamm. 2014:312484.
   PubMed Web of Science ®Google Scholar
• Muijsers RB, Van Den Worm E, Folkerts G, Beukelman CJ, Koster AS, Postma DS, Nijkamp FP. 2000. Apocynin inhibits peroxynitrite formation by murine macrophages. Br J Pharmacol. 130:932–936.
   PubMed Web of Science ®Google Scholar
• Naito Y, Takagi T, Yoshikawa T. 2004. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment Pharmacol Ther. 20(Suppl 1):177–184.
   PubMed Web of Science ®Google Scholar
• Nam YJ, Kim A, Sohn DS, Lee CS. 2016. Apocynin inhibits toll-like receptor-4-mediated activation of NF-kappaB by suppressing the Akt and mTOR pathways. Naunyn Schmiedebergs Arch Pharmacol. 389:1267–1277.
   Web of Science ®Google Scholar
• Ochi R, Gupte R, Murayama T, Kurebayashi N, Gupte S. 2010. Apocynin reversibly inhibits L-type Ca2+ channel current involvement of reactive oxygen species. Biophysical J. 98:134a–135a.
   Web of Science ®Google Scholar
• Ochi R, Gupte S. 2011. Apocynin induces rapid inhibition and slow facilitation of ICa, L and decrease and increase of reactive oxygen species in rat ventricular myocytes. Biophysical J. 100:197a.
   Web of Science ®Google Scholar
• Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. 1988. Interleukin 1 induces a shock-like state in rabbits. synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 81:1162–1172.
   PubMed Web of Science ®Google Scholar
• Oostwoud LC, Gunasinghe P, Seow HJ, Ye JM, Selemidis S, Bozinovski S, Vlahos R. 2016. Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice. Sci Rep. 6:20983.
   PubMed Web of Science ®Google Scholar
• Pan L, Qian S. 2018. Apocynin promotes neural function recovery and suppresses neuronal apoptosis by inhibiting Tlr4/NF-B signaling pathway in a rat model of cerebral infarction. Int J Immunopathol Pharmacol. 32:1–11.
   Web of Science ®Google Scholar
• Pandey A, Kour K, Bani S, Suri KA, Satti NK, Sharma P, Qazi GN. 2009. Amelioration of adjuvant induced arthritis by apocynin. Phytother Res. 23:1462–1468.
   PubMed Web of Science ®Google Scholar
• Pawate S, Shen Q, Fan F, Bhat NR. 2004. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res. 77:540–551.
   PubMed Web of Science ®Google Scholar
• Pechanova O, Jendekova L, Vrankova S. 2009. Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension. Pharmacol Rep. 61:116–122.
   PubMed Web of Science ®Google Scholar
• Peters E, Hiltermann J, Stolk J. 2001. Effectofapocynin onozone-inducedairwayhyperresponsivenesstomethacholine in asthmatics. Free Radical Biol Med. 31:1442–1447.
   PubMed Web of Science ®Google Scholar
• Rajman L, Chwalek K, Sinclair DA. 2018. Therapeutic potential of NAD-boosting molecules: The In vivo evidence. Cell Metab. 27:529–547.
   PubMed Web of Science ®Google Scholar
• Ramonaite R, Skieceviciene J, Juzenas S, Salteniene V, Kupcinskas J, Matusevicius P, Borutaite V, Kupcinskas L. 2014. Protective action of NADPH oxidase inhibitors and role of NADPH oxidase in pathogenesis of colon inflammation in mice. World J Gastroenterol. 20:12533–12541.
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. 2010. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 49:1603–1616.
   PubMed Web of Science ®Google Scholar
• Riganti C, Costamagna C, Doublier S, Miraglia E, Polimeni M, Bosia A, Ghigo D. 2008. The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol Appl Pharmacol. 228:277–285.
   PubMed Web of Science ®Google Scholar
• Sadeghi-Hashjin G, Folkerts G, Henricks PA, Muijsers RB, Nijkamp FP. 1998. Peroxynitrite in airway diseases. Clin Exp Allergy. 28:1464–1473.
   PubMed Web of Science ®Google Scholar
• Sadeghi-Hashjin G, Folkerts G, Henricks PA, Verheyen AK, Van Der Linde HJ, Van Ark I, Coene A, Nijkamp FP. 1996. Peroxynitrite induces airway hyperresponsiveness in Guinea pigs in vitro and in vivo. Am J Respir Crit Care Med. 153:1697–1701.
   PubMed Web of Science ®Google Scholar
• Shibata H, Katsuki H, Okawara M, Kume T, Akaike A. 2006. . c-Jun N-terminal kinase inhibition and alpha-tocopherol protect midbrain dopaminergic neurons from interferon-gamma/lipopolysaccharide-induced injury without affecting nitric oxide production. J Neurosci Res. 83:102–109.
   PubMed Web of Science ®Google Scholar
• Simonyi A, Serfozo P, Lehmidi TM, Cui J, Gu Z, Lubahn DB, Sun AY, Sun GY. 2012. The neuroprotective effects of apocynin. Front Biosci (Elite Ed). 4:2183–2193.
   PubMedGoogle Scholar
• Stefanska J, Pawliczak R. 2008. Apocynin: molecular aptitudes. Mediators Inflamm. 2008:106507.
   PubMed Web of Science ®Google Scholar
• Stefanska J, Sarniak A, Wlodarczyk A, Sokolowska M, Pniewska E, Doniec Z, Nowak D, Pawliczak R. 2012. Apocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmatics. Exp Lung Res. 38:90–99.
   PubMed Web of Science ®Google Scholar
• Stefanska J, Sokolowska M, Sarniak A, Wlodarczyk A, Doniec Z, Nowak D, Pawliczak R. 2010. Apocynin decreases hydrogen peroxide and nitrate concentrations in exhaled breath in healthy subjects. Pulm Pharmacol Ther. 23:48–54.
   PubMed Web of Science ®Google Scholar
• Steinkamp-Fenske K, Bollinger L, Xu H, Yao Y, Horke S, Forstermann U, Li H. 2007. Reciprocal regulation of endothelial nitric-oxide synthase and NADPH oxidase by betulinic acid in human endothelial cells. J Pharmacol Exp Ther. 322:836–842.
   PubMed Web of Science ®Google Scholar
• Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. 1994a. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol. 11:95–102.
   PubMed Web of Science ®Google Scholar
• Stolk J, Rossie W, Dijkman JH. 1994b. Apocynin improves the efficacy of secretory leukocyte protease inhibitor in experimental emphysema. Am J Respir Crit Care Med. 150:1628–1631.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Pitchakarn P, Sato S, Shirai T, Takahashi S. 2013a. Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation. Exp Toxicol Pathol. 65:1035–1041.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Shiraga K, Sato S, Punfa W, Naiki-Ito A, Yamashita Y, Shirai T, Takahashi S. 2013b. Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis. Cancer Sci. 104:1711–1717.
   Web of Science ®Google Scholar
• Tang LL, Ye K, Yang XF, Zheng JS. 2007. Apocynin attenuates cerebral infarction after transient focal ischaemia in rats. J Int Med Res. 35:517–522.
   PubMed Web of Science ®Google Scholar
• Taylor NE, Glocka P, Liang M, Cowley AW, Jr. 2006. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension. 47:692–698.
   PubMed Web of Science ®Google Scholar
• Tian T, Wang Z, Zhang J. 2017. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential Antioxidant therapies. Oxid Med Cell Longev. 2017:4535194.
   PubMed Web of Science ®Google Scholar
• Touyz RM. 2008. Apocynin, NADPH oxidase, and vascular cells: a complex matter. Hypertension. 51:172–174.
   PubMed Web of Science ®Google Scholar
• Uysal A, Sahna E, Ozguler IM, Burma O, Ilhan N. 2015. Effects of apocynin, an NADPH oxidase inhibitor, on levels of ADMA, MPO, iNOS and TLR4 induced by myocardial ischemia reperfusion. Perfusion. 30:472–477.
   PubMed Web of Science ®Google Scholar
• Van den Worm E, Beukelman CJ, Van den Berg AJ, Kroes BH, Labadie RP, Van Dijk H. 2001. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol. 433:225–230.
   PubMed Web of Science ®Google Scholar
• Vejrazka M, Micek R, Stipek S. 2005. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta. 1722:143–147.
   PubMed Web of Science ®Google Scholar
• Wang Q, Smith RE, Luchtefeld R, Sun AY, Simonyi A, Luo R, Sun GY. 2008. Bioavailability of apocynin through its conversion to glycoconjugate but not to diapocynin. Phytomedicine. 15:496–503.
   PubMed Web of Science ®Google Scholar
• Wang Q, Tompkins KD, Simonyi A, Korthuis RJ, Sun AY, Sun GY. 2006. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res. 1090:182–189.
   PubMed Web of Science ®Google Scholar
• Wang W, Suzuki Y, Tanigaki T, Rank DR, Raffin TA. 1994. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in Guinea pigs. Am J Respir Crit Care Med. 150:1449–1452.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2020. Coronavirus disease 2019 (COVID-19). Situation Report – 67.
   Google Scholar
• Ximenes VF, Kanegae MP, Rissato SR, Galhiane MS. 2007. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch Biochem Biophys. 457:134–141.
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al. 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 8:420–422.
   PubMed Web of Science ®Google Scholar
• Zalinger ZB, Elliott R, Weiss SR. 2017. Role of the inflamma some-related cytokines Il-1 and Il-18 during infection with murine coronavirus. J Neurovirol. 23:845–854.
   PubMed Web of Science ®Google Scholar